Industry News
Research looks at correlation between OCD, body dysmorphia and tanning addiction
Feb 22, 2014
They keep tanning, even after turning a deep brown and experiencing some of the negative consequences. Skin cancer is among the most common, preventable types of the disease, yet many continue to tan to excess.Research from Lisham Ashrafioun, a Bowling Green State University Ph.D. student in psychology, and Dr. Read More
Inherited predisposition to leukemia found in infants
Feb 22, 2014
Babies who develop leukemia during the first year of life appear to inherit an unfortunate combination of genetic variations that can make the infants highly susceptible to the disease, according to a new study at Washington University School of Medicine in St. Louis and the University of Minnesota.The research is available online in the journal Leukemia. Read More
Researchers discover targeted way to treat ovarian cancer
Feb 22, 2014
Researchers at Women & Infants Hospital of Rhode Island have developed a biologic drug that would prevent the production of a protein known to allow ovarian cancer cells to grow aggressively while being resistant to chemotherapy. This would improve treatment and survival rates for some women.The work coming out of the molecular therapeutic laboratory directed by Richard G. Read More
Research looks at correlation between OCD, body dysmorphia and tanning addiction
Feb 22, 2014
They keep tanning, even after turning a deep brown and experiencing some of the negative consequences. Skin cancer is among the most common, preventable types of the disease, yet many continue to tan to excess.Research from Lisham Ashrafioun, a Bowling Green State University Ph.D. student in psychology, and Dr. Read More
Inherited predisposition to leukemia found in infants
Feb 22, 2014
Babies who develop leukemia during the first year of life appear to inherit an unfortunate combination of genetic variations that can make the infants highly susceptible to the disease, according to a new study at Washington University School of Medicine in St. Louis and the University of Minnesota.The research is available online in the journal Leukemia. Read More
Personal Genome Diagnostics' Circulating Tumor DNA technology highlighted in landmark study
Feb 21, 2014
Personal Genome Diagnostics Inc. (PGDx), a provider of advanced cancer genome analysis and testing services, reported that its proprietary technology was used in a major new study being published in the journal Science Translational Medicine. Read More
Advanced prostate cancer risk could be identified by genetic screening
Feb 21, 2014
New research from the Institute of Cancer Research in the UK suggests that screening men with a family history of prostate cancer for certain gene mutations could identify those who are at increased risk of aggressive forms of the disease and need lifelong monitoring. Read More
Added benefit of Afatinib depends on mutation status in non-small cell lung cancer
Feb 21, 2014
Lung cancer patients with Del19 mutation benefit mostAfatinib (trade name: GIOTRIF) has been approved in Germany since September 2013 for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating EGF receptor mutations who have not been treated with an EGF receptor tyrosine-kinase inhibitor (EGFR TKI). Read More
Reduced risk of cervical lesions associated with HPV vaccination in Denmark
Feb 21, 2014
A reduced risk of cervical lesions among Danish girls and women at the population level is associated with use of a quadrivalent HPV vaccine after only six years, according to a new study published in the Journal of the National Cancer Institute.Two HPV vaccines are currently available and have proven to be highly effective against HPV16/18-associated cervical cancer. Read More
Overall survival not improved by adding bevacizumab to initital glioblastoma treatment
Feb 21, 2014
Glioblastoma (GBM) is the most common primary malignant adult brain tumor and, despite treatment advances in recent years, the average survival of patients enrolled in clinical trials is less than 16 months with few patients living beyond five years. Read More
Previous Page Next Page